Aside from vaccines, the advent of several effective COVID-19 antiviral therapies, including Pfizer’s Paxlovid, provides hope for ending the pandemic. Details about the U.S. government’s contract with Pfizer for 10 million doses of Paxlovid are emerging, with some unusual elements.
The spread of COVID-19 in the Americas driven by the Omicron variant of the virus reached levels of transmission never before seen during the pandemic, with cases doubling to 6.1 million over the past week, the Pan American Health Organization (PAHO) said on January 12.
Covid-19 is slowly retreating across most of North, Central and South America, the Pan American Health Organization (PAHO) said on Oct. 27, reporting that last week the continent’s death and infection figures were the lowest in over a year.
New Covid-19 cases continue to decline in North America, but in Latin America infections are still rising, particularly in Brazil where a resurgence has caused record daily deaths, the Pan American Health Organization (PAHO) warned on March 10.
COVID-19 cases still surging in the Americas, the WHO warns BRASILIA (Reuters) – COVID-19 cases are still surging in the Americas, averaging 150,000 a day in last week, the World […]
A Cuban-developed lung cancer treatment combined with Bristol-Myers Squibb’s anti-PDL1 Opdivo shows promise in treating patients who would not likely benefit from immune checkpoint inhibition.
Cuba reported its first case of Zika on Wednesday, diagnosed in a 28-year-old Venezuelan doctor whose husband and brother-in-law previously contracted the virus in their home country. The World […]